This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in Journal of Participatory Medicine, is properly cited. The complete bibliographic information, a link to the original publication on https://jopm.jmir.org, as well as this copyright and license information must be included.
In “Data Sharing Goals for Nonprofit Funders of Clinical Trials” (J Particip Med 2021;13(1):e23011) the authors noted two errors.
In the originally published manuscript, Lynn Matrisian was the last author listed in the order of authorship. This has been corrected to place Lynn Matrisian fifteenth in the order of authorship, after Mary Jane Marchisotto and before Elizabeth Myers. Author affiliations have been renumbered accordingly.
As well, the affiliation for Mary Jane Marchisotto has been corrected from:
MJM Advisory, LLC, McLean, VA, United States
to:
MJM Advisory, LLC, New York, NY, United States
The complete list of authors and affiliations in the originally published paper was as follows:
Timothy Coetzee1, MSc, PhD; Mad Price Ball2, PhD; Marc Boutin3, JD; Abby Bronson4, MBA; David T Dexter5, PhD; Rebecca A English6, MPH; Patricia Furlong7, BSN; Andrew D Goodman8, MD; Cynthia Grossman9, PhD; Adrian F Hernandez10, MD, MHS; Jennifer E Hinners11, MPH, MD; Lynn Hudson12, PhD; Annie Kennedy7, BSc; Mary Jane Marchisotto13, MBA; Elizabeth Myers14, PhD; W Benjamin Nowell15, PhD; Brian A Nosek16, PhD; Todd Sherer17, PhD; Carolyn Shore6, PhD; Ida Sim18, PhD, MD; Luba Smolensky17, BA; Christopher Williams19, MSc; Julie Wood20, BA; Sharon F Terry21, MA, LhD; Lynn Matrisian22, PhD, MBA
1National Multiple Sclerosis Society, Cherry Hill, NJ, United States
2Open Humans Foundation, San Diego, CA, United States
3Novartis, Basel, Switzerland
4Edgewise Therapeutics, Boulder, CO, United States
5Parkinson’s UK, London, United Kingdom
6National Academies of Sciences, Engineering, and Medicine, Washington, DC, United States
7Parent Project Muscular Dystrophy, Bethesda, MD, United States
8Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States
9Biogen, Cambridge, MA, United States
10Duke University School of Medicine, Durham, NC, United States
11Bison Ink, Washington, DC, United States
12Critical Path Institute, Tucson, AZ, United States
13MJM Advisory, LLC, McLean, VA, United States
14Doris Duke Charitable Foundation, New York, NY, United States
15Global Healthy Living Foundation, Upper Nyack, NY, United States
16Center for Open Science, Charlottesville, VA, United States
17The Michael J Fox Foundation for Parkinson’s Research, New York, NY, United States
18Department of Medicine, University of California San Francisco, San Francisco, CA, United States
19Multiple Myeloma Research Foundation, Norwalk, CT, United States
20Vivli, Columbia, MO, United States
21Genetic Alliance, Washington, DC, United States
22Pancreatic Cancer Action Network, Washington, DC, United States
The complete list of authors and affiliations in the corrected paper is as follows:
Timothy Coetzee1, MSc, PhD; Mad Price Ball2, PhD; Marc Boutin3, JD; Abby Bronson4, MBA; David T Dexter5, PhD; Rebecca A English6, MPH; Patricia Furlong7, BSN; Andrew D Goodman8, MD; Cynthia Grossman9, PhD; Adrian F Hernandez10, MD, MHS; Jennifer E Hinners11, MPH, MD; Lynn Hudson12, PhD; Annie Kennedy7, BSc; Mary Jane Marchisotto13, MBA; Lynn Matrisian14, PhD, MBA; Elizabeth Myers15, PhD; W Benjamin Nowell16, PhD; Brian A Nosek17, PhD; Todd Sherer18, PhD; Carolyn Shore6, PhD; Ida Sim19, PhD, MD; Luba Smolensky18, BA; Christopher Williams20, MSc; Julie Wood21, BA; Sharon F Terry22, MA, LhD
1National Multiple Sclerosis Society, Cherry Hill, NJ, United States
2Open Humans Foundation, San Diego, CA, United States
3Novartis, Basel, Switzerland
4Edgewise Therapeutics, Boulder, CO, United States
5Parkinson’s UK, London, United Kingdom
6National Academies of Sciences, Engineering, and Medicine, Washington, DC, United States
7Parent Project Muscular Dystrophy, Bethesda, MD, United States
8Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States
9Biogen, Cambridge, MA, United States
10Duke University School of Medicine, Durham, NC, United States
11Bison Ink, Washington, DC, United States
12Critical Path Institute, Tucson, AZ, United States
13MJM Advisory, LLC, New York, NY, United States
14Pancreatic Cancer Action Network, Washington, DC, United States
15Doris Duke Charitable Foundation, New York, NY, United States
16Global Healthy Living Foundation, Upper Nyack, NY, United States
17Center for Open Science, Charlottesville, VA, United States
18The Michael J Fox Foundation for Parkinson’s Research, New York, NY, United States
19Department of Medicine, University of California San Francisco, San Francisco, CA, United States
20Multiple Myeloma Research Foundation, Norwalk, CT, United States
21Vivli, Columbia, MO, United States
22Genetic Alliance, Washington, DC, United States
The correction will appear in the online version of the paper on the JMIR Publications website on June 30, 2021, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.